glucuronyl-glucosamine-glycan-sulfate has been researched along with Diabetic-Foot* in 2 studies
2 other study(ies) available for glucuronyl-glucosamine-glycan-sulfate and Diabetic-Foot
| Article | Year |
|---|---|
[Metabolic therapy at patients with a syndrome of diabetic foot].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprostadil; Diabetic Foot; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Plastic Surgery Procedures; Regional Blood Flow; Retrospective Studies; Surgical Flaps; Syndrome; Treatment Outcome; Vasodilator Agents; Young Adult | 2013 |
[Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
To evaluate effectiveness of sulodexide in patients with pyonecrotic complications of diabetic foot.. Sulodexide was given to 15 patients which were examined for blood fibrinogen, foot tissues saturation with oxygen, microbic contamination of the wound tissue. In addition, ultrasound dopplerography of foot arteries, laser doppler flowmetry were performed.. Fibrinogen in peripheral blood fell, arteriovenous shunting diminished, capillary blood flow and oxygen saturation of the tissues improved.. Even early sulodexide treatment is effective at different stages of the pathological process in diabetic patients with severe pyonecrotic lesion of the lower limbs as it recovers microcirculatory blood flow. Topics: Diabetic Foot; Glycosaminoglycans; Humans; Hypoglycemic Agents; Microcirculation; Necrosis; Suppuration; Time Factors | 2001 |